US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
GB9517779D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US7332648B2
(en)
|
1995-08-31 |
2008-02-19 |
Roslin Institute |
Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
AU4984697A
(en)
|
1996-10-11 |
1998-05-11 |
The Texas A & M University System |
Methods for the generation of primordial germ cells and transgenic animal species
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
WO1998048005A1
(en)
*
|
1997-04-24 |
1998-10-29 |
University Of Washington |
Targeted gene modification by parvoviral vectors
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
CA2294472C
(en)
|
1997-06-19 |
2010-06-15 |
The General Hospital Corporation |
Torsin, torsin genes, and methods of use
|
CN101003800A
(zh)
*
|
1997-07-03 |
2007-07-25 |
马萨诸塞大学 |
使用来自无血清饥饿的分化细胞的供体细胞核进行克隆
|
AU8587598A
(en)
*
|
1997-07-26 |
1999-02-16 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
CA2300972A1
(en)
*
|
1997-08-22 |
1999-03-04 |
Biotechnology And Biological Sciences Research Council |
Use of mariner transposan in the production of transgenic animals
|
WO1999021415A1
(en)
*
|
1997-10-28 |
1999-05-06 |
Stem Cell Sciences Pty. Ltd. |
Nuclear transfer for production of transgenic animal embryo
|
JP4102450B2
(ja)
*
|
1998-01-16 |
2008-06-18 |
アグロバイオジェン ゲーエムベーハー |
胎仔線維芽細胞による効率的な核移入
|
US6331659B1
(en)
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
EP1067834A4
(en)
*
|
1998-03-16 |
2002-01-23 |
Garelag Pty Ltd |
PORCINE CELL CORE TRANSFER
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
AU6218899A
(en)
*
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
EP1375654A3
(en)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
EP1127113A2
(en)
*
|
1998-11-02 |
2001-08-29 |
Genzyme Transgenics Corporation |
Transgenic and cloned mammals
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
CA2351943A1
(en)
|
1998-11-19 |
2000-06-02 |
Ppl Therapeutics (Scotland) Limited |
Stabilisation of milk from transgenic animals
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
JP2002534118A
(ja)
*
|
1999-01-13 |
2002-10-15 |
ピーピーエル セラピューティクス (スコットランド) リミテッド |
二重核移植法及びその結果物
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
WO2000050443A2
(en)
|
1999-02-26 |
2000-08-31 |
Millennium Pharmaceutcals, Inc. |
Secreted proteins and uses thereof
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
AU780754B2
(en)
*
|
1999-03-04 |
2005-04-14 |
Revivicor Inc |
Genetic modification of somatic cells and uses thereof
|
BR0010588A
(pt)
*
|
1999-04-28 |
2003-07-22 |
Univ Montreal |
Oócitos enucleados de telofase para transferência nuclear
|
EP1191840B1
(en)
*
|
1999-06-04 |
2007-01-17 |
Istituto Zootecnico E Caseario per La Sardegna |
Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom.
|
EP1194570A1
(en)
|
1999-06-23 |
2002-04-10 |
PPL Therapeutics (Scotland) Limited |
Fusion proteins incorporating lysozyme
|
CN1362965A
(zh)
|
1999-06-30 |
2002-08-07 |
先进细胞技术公司 |
细胞质转移使受体细胞去分化
|
AU5577600A
(en)
*
|
1999-06-30 |
2001-01-31 |
Woo-Suk Hwang |
A method for producing human embryonic skin cells by employing an inter-species nuclear transplantation technique
|
US6590139B1
(en)
|
1999-06-30 |
2003-07-08 |
Woo-Suk Hwang |
Method for producing cloned cows
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
JP2003503045A
(ja)
*
|
1999-06-30 |
2003-01-28 |
ワン,ウー−サク |
異種間核移植技術を用いたクローントラの生産方法
|
EP1210428B1
(en)
|
1999-08-23 |
2015-03-18 |
Dana-Farber Cancer Institute, Inc. |
Pd-1, a receptor for b7-4, and uses therefor
|
EP2275559A3
(en)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimized messenger RNA
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
CN1402781A
(zh)
*
|
1999-09-30 |
2003-03-12 |
根茨美转基因公司 |
克隆和转基因哺乳动物的生产方法
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
WO2001068831A2
(en)
|
2000-03-15 |
2001-09-20 |
The University Of Georgia Research Foundation, Inc. |
Effective nuclear reprogramming in mammals
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
AU2001261650A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
EP1297135B1
(en)
|
2000-06-28 |
2013-01-09 |
Genetics Institute, LLC |
Pd-l2 molecules: novel pd-1 ligands and uses therefor
|
WO2002009510A2
(en)
*
|
2000-08-01 |
2002-02-07 |
Xy Genetics, Llc |
Methods of selecting and cloning animals
|
CN1468250A
(zh)
|
2000-08-03 |
2004-01-14 |
��ķһ����˹��̹ |
在转基因动物中产生人源化抗体
|
AU2001284948A1
(en)
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
WO2002019811A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
AU2002241524A1
(en)
|
2000-11-28 |
2002-06-11 |
Wyeth |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
AU2002236503C1
(en)
|
2000-11-28 |
2008-11-13 |
Wyeth |
Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
ATE466089T1
(de)
|
2000-12-22 |
2010-05-15 |
Agronomique Inst Nat Rech |
Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
|
MXPA03005624A
(es)
*
|
2000-12-22 |
2004-12-03 |
Vaurox Llc |
Metodos para clonar mamiferos usando cromatina reprogramada del donador o celulas donadoras.
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
EP1860199B1
(en)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulating insulin receptor signaling
|
WO2002074078A2
(en)
|
2001-01-30 |
2002-09-26 |
Rebholtz, Amy, K. |
Method for embryo after impregnation of the recipient female
|
WO2002062131A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Infigen, Inc. |
Method of cloning transgenic mammalian animals using pseudonuclei
|
CA2438119C
(en)
*
|
2001-02-20 |
2014-12-16 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
US7309811B2
(en)
|
2001-02-23 |
2007-12-18 |
Elan Pharmaceuticals, Inc |
Transgenic mice knockouts of BACE-1
|
JP2002262716A
(ja)
*
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
AU2002258477A1
(en)
*
|
2001-03-08 |
2002-09-24 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2002074935A2
(en)
*
|
2001-03-21 |
2002-09-26 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
WO2002078449A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Advanced Cell Technology, Inc. |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
AU2002338272B2
(en)
|
2001-04-02 |
2007-10-11 |
Dana-Farber Cancer Institute, Inc. |
PD-1, a receptor for B7-4, and uses therefor
|
EP2261241A1
(en)
|
2001-04-16 |
2010-12-15 |
Wyeth Holdings Corporation |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
US20030092174A1
(en)
*
|
2001-05-14 |
2003-05-15 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
WO2003005810A2
(en)
*
|
2001-07-09 |
2003-01-23 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
WO2003006477A1
(en)
|
2001-07-12 |
2003-01-23 |
University Of Massachusetts |
IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING
|
EP1900815B1
(en)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
AU2002326483A1
(en)
*
|
2001-07-31 |
2003-02-17 |
Simon Eric Aspland |
Genetically modified cows having reduced susceptibility to mad cow disease
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
CA2466415C
(en)
|
2001-11-09 |
2020-01-21 |
Dana-Farber Cancer Institute, Inc. |
Pgc-1.beta., a novel pgc-1 homologue and uses therefor
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
CA2474486C
(en)
*
|
2002-01-23 |
2013-05-14 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
ATE531796T1
(de)
*
|
2002-03-21 |
2011-11-15 |
Sangamo Biosciences Inc |
Verfahren und zusammensetzungen zur verwendung von zinkfinger-endonukleasen zur verbesserung der homologen rekombination
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
EP1490487A4
(en)
*
|
2002-04-01 |
2007-08-29 |
Gtc Biotherapeutics Inc |
METHOD FOR SELECTING CELLULAR LINES SUITABLE FOR CORE TRANSFER IN MAMMAL SPECIES
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
WO2003104423A2
(en)
*
|
2002-06-11 |
2003-12-18 |
Roy Ogle |
Meningeal-derived stem cells
|
US7612250B2
(en)
*
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
EP2311978A1
(en)
|
2002-08-20 |
2011-04-20 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
US9447434B2
(en)
*
|
2002-09-05 |
2016-09-20 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
CA2501752A1
(en)
|
2002-10-10 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
US7208306B2
(en)
|
2002-10-24 |
2007-04-24 |
Wyeth |
Compositions employing a novel human protein phosphatase
|
EP1563084A4
(en)
|
2002-11-08 |
2006-03-01 |
Hematech Llc |
TRANSGENE UNGULATES WITH REDUCED PRION PROTEIN ACTIVITY AND USES THEREOF
|
CA2505416A1
(en)
|
2002-11-21 |
2004-06-10 |
Wyeth |
Methods for diagnosing rcc and other solid tumors
|
AU2003290664A1
(en)
|
2002-11-27 |
2004-06-23 |
Wei Liu |
Compositions, organisms and methodologies employing a novel human kinase
|
JP2006508676A
(ja)
*
|
2002-12-10 |
2006-03-16 |
ジーティーシー バイオセラピューティックス インコーポレイテッド |
追加の核移植のための細胞ドナーとして体細胞核移植胚を利用する方法および系
|
EP2500440B1
(en)
|
2002-12-20 |
2015-12-16 |
Celera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
EP1581812B1
(en)
|
2003-01-06 |
2008-07-16 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
EP3502252B1
(en)
|
2003-06-02 |
2023-04-05 |
University of Massachusetts |
Methods and compositions for controlling efficacy of rna silencing
|
ATE485394T1
(de)
|
2003-06-02 |
2010-11-15 |
Univ Massachusetts |
Verfahren und zusammensetzungen zur verbesserung der wirksamkeit und spezifität von fnai
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
EP1654349A4
(en)
|
2003-08-14 |
2008-08-20 |
Exelixis Inc |
SULFS AS BETA-CATENIN PATH MODIFICATORS AND METHOD OF USE
|
CN102517381A
(zh)
|
2003-10-07 |
2012-06-27 |
千年药品公司 |
用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
|
WO2005046450A2
(en)
|
2003-11-12 |
2005-05-26 |
Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
CA3048093A1
(en)
|
2003-11-26 |
2005-06-23 |
Celera Corporation |
Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
CN101014715A
(zh)
*
|
2004-04-22 |
2007-08-08 |
麒麟麦酒株式会社 |
转基因动物及其用途
|
EP1745154B1
(en)
|
2004-05-07 |
2012-08-01 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
WO2006047312A2
(en)
|
2004-10-22 |
2006-05-04 |
Dana-Farber Cancer Institute, Inc. |
COMPOSITIONS AND METHODS FOR MODULATING PGC-1β TO TREAT LIPID-RELATED DISEASES AND DISORDERS
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
EP1856296A2
(en)
|
2005-03-11 |
2007-11-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
CA2612479A1
(en)
*
|
2005-06-29 |
2007-05-10 |
Cameron Malcolm Lang Clokie |
Production of bone morphogenic proteins (bmps) in transgenic mammals
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
NZ565711A
(en)
|
2005-08-09 |
2011-10-28 |
Revivicor Inc |
Transgenic ungulates expressing a porcine CTLA4 peptide fused to an immunoglobulin
|
AU2006287315B2
(en)
|
2005-09-09 |
2013-02-21 |
The Johns Hopkins University |
Manipulation of regulatory T cell and DC function by targeting neuritin gene using antibodies, agonists and antagonists
|
AU2006292224B2
(en)
|
2005-09-19 |
2013-08-01 |
Histogenics Corporation |
Cell-support matrix and a method for preparation thereof
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
US8173860B2
(en)
|
2006-04-21 |
2012-05-08 |
Gtc Biotherapeutics, Inc. |
Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
|
CN102719444B
(zh)
|
2006-09-01 |
2016-12-14 |
人类多细胞株治疗学公司 |
人或人源化免疫球蛋白在非人转基因动物中增强的表达
|
US7993833B2
(en)
|
2006-09-11 |
2011-08-09 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
CA2915679C
(en)
|
2006-10-20 |
2017-12-12 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
WO2008085891A1
(en)
*
|
2007-01-05 |
2008-07-17 |
Worcester Polytechnic Institute |
Oocyte spindle-associated factors improve somatic cell cloning
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
EP2214708A4
(en)
|
2007-10-26 |
2011-01-12 |
Centocor Ortho Biotech Inc |
VECTORS, HOST CELLS, METHODS OF PRODUCTION AND USES
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
KR101105248B1
(ko)
|
2008-01-04 |
2012-01-17 |
재단법인서울대학교산학협력재단 |
형질전환된 복제개의 생산방법
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
EP2987498B1
(en)
|
2008-05-02 |
2017-07-05 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Treatment of bleeding with low half-life fibrinogen
|
US9238797B2
(en)
|
2008-07-07 |
2016-01-19 |
Takara Bio Inc. |
Method for production of pluripotent stem cell
|
EP2733222A1
(en)
|
2008-07-09 |
2014-05-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
EP2421980A2
(en)
|
2009-04-23 |
2012-02-29 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cancer
|
EP2267153A1
(en)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identification of netrin-1 receptor unc5c gene mutation in solid cancers
|
US9314005B2
(en)
|
2009-07-01 |
2016-04-19 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (SCID)
|
EP2456876A2
(en)
|
2009-07-24 |
2012-05-30 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
US20110035816A1
(en)
|
2009-08-05 |
2011-02-10 |
Ostertag Eric M |
Genetically Modified Rat Models for Drug Metabolism
|
WO2011022634A2
(en)
|
2009-08-20 |
2011-02-24 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
JP2013520162A
(ja)
|
2010-01-22 |
2013-06-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
CA3079122A1
(en)
|
2010-03-26 |
2011-09-29 |
Trustees Of Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
EP2603581B1
(en)
|
2010-08-11 |
2019-07-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cocultures of cumulus cells and embryos during in vitro fertilization procedures
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US8748178B2
(en)
|
2010-11-23 |
2014-06-10 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
ES2680636T3
(es)
|
2011-02-14 |
2018-09-10 |
Revivicor Inc. |
Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
KR102627319B1
(ko)
|
2011-05-16 |
2024-01-23 |
더 큐레이터스 오브 더 유니버시티 오브 미주리 |
돼지 생식기 호흡기 증후군 바이러스 내성 동물
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
EP2814842B1
(en)
|
2012-02-15 |
2018-08-22 |
Novo Nordisk A/S |
Antibodies that bind peptidoglycan recognition protein 1
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP3196214B1
(en)
|
2012-02-15 |
2019-07-31 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
|
WO2013192504A1
(en)
|
2012-06-22 |
2013-12-27 |
The Trustees Of Dartmouth College |
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CN109793893B
(zh)
|
2012-09-07 |
2023-05-26 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
WO2014140927A2
(en)
|
2013-02-13 |
2014-09-18 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
KR20160002713A
(ko)
|
2013-02-13 |
2016-01-08 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
|
DK2993234T3
(en)
|
2013-04-30 |
2019-01-07 |
Univ Konkuk Ind Coop Corp |
Vector Targeted CMP Acetylneuramic Acid Hydroxylase, Transgenic Animal for Xenotransplantation Introduced with the Vector and Method of Preparation thereof
|
EP4043493A1
(en)
|
2013-12-24 |
2022-08-17 |
Janssen Pharmaceutica NV |
Anti-vista antibodies and fragments
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
US20160340407A1
(en)
|
2014-01-14 |
2016-11-24 |
Dana-Farber Camcer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
|
US11123426B2
(en)
|
2014-06-11 |
2021-09-21 |
The Trustees Of Dartmouth College |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
KR102465120B1
(ko)
|
2014-07-17 |
2022-11-10 |
노보 노르디스크 에이/에스 |
점도를 감소시키기 위한 trem-1 항체의 부위 지정 돌연변이유발
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
KR102457921B1
(ko)
|
2014-12-09 |
2022-10-25 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화 분화 클러스터 274 유전자를 갖는 비인간 동물
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
MX2017016647A
(es)
|
2015-06-24 |
2019-04-25 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
WO2017023570A1
(en)
|
2015-08-06 |
2017-02-09 |
The Curators Of The University Of Missouri |
Pathogen-resistant animals having modified cd163 genes
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
MX2018009800A
(es)
|
2016-02-12 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
|
CA3020848A1
(en)
|
2016-04-15 |
2017-10-19 |
Janssen Pharmaceuticals, Inc. |
Anti-human vista antibodies and use thereof
|
KR20200139219A
(ko)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
항-trem-1 항체 및 이의 용도
|
CN112272516B
(zh)
|
2018-04-06 |
2023-05-30 |
儿童医疗中心有限公司 |
用于体细胞重新编程和调整印记的组合物和方法
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
EP4077376A2
(en)
|
2019-12-19 |
2022-10-26 |
Quidel Corporation |
Monoclonal antibody fusions
|
CA3196707A1
(en)
|
2020-11-20 |
2022-05-27 |
Martine Rothblatt |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
IL311538A
(en)
|
2021-09-20 |
2024-05-01 |
Revivicor Inc |
Transgenic multigene pigs comprising ten genetic alterations for xenotransplantation
|